BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18328143)

  • 1. Resource utilization and the cost of rheumatoid arthritis in Brazil.
    Chermont GC; Kowalski SC; Ciconelli RM; Ferraz MB
    Clin Exp Rheumatol; 2008; 26(1):24-31. PubMed ID: 18328143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource utilisation and cost of ankylosing spondylitis in Brazil.
    Torres TM; Ferraz MB; Ciconelli RM
    Clin Exp Rheumatol; 2010; 28(4):490-7. PubMed ID: 20810034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource utilization and cost of rheumatic fever.
    Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
    J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K; Messer J; Choi HK; Wolfe F
    Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect costs of rheumatoid arthritis in Brazil.
    de Azevedo AB; Ferraz MB; Ciconelli RM
    Value Health; 2008; 11(5):869-77. PubMed ID: 18489511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource utilization in postmenopausal osteoporosis without incident fractures.
    Kowalski SC; Sjenzfeld VL; Ferraz MB
    J Rheumatol; 2004 May; 31(5):938-42. PubMed ID: 15124254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
    Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
    J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs.
    Lanes SF; Lanza LL; Radensky PW; Yood RA; Meenan RF; Walker AM; Dreyer NA
    Arthritis Rheum; 1997 Aug; 40(8):1475-81. PubMed ID: 9259428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain].
    Mera Varela A; Blanco Rodríguez J; Caamaño Freire M
    An Med Interna; 2003 Mar; 20(3):114-21. PubMed ID: 12756895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding Rheumatoid Arthritis Impact on Life (FRAIL Study): economic burden.
    Miranda LC; Santos H; Ferreira J; Coelho P; Silva C; Saraiva-Ribeiro J;
    Acta Reumatol Port; 2012; 37(2):134-42. PubMed ID: 23149635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
    Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
    Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rheumatoid arthritis on quality of life, work productivity and resource utilisation: an observational, cross-sectional study in Brazil.
    da Rocha Castelar Pinheiro G; Khandker RK; Sato R; Rose A; Piercy J
    Clin Exp Rheumatol; 2013; 31(3):334-40. PubMed ID: 23324808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis.
    Álvarez-Hernández E; Peláez-Ballestas I; Boonen A; Vázquez-Mellado J; Hernández-Garduño A; Rivera FC; Teran-Estrada L; Ventura-Ríos L; Ramos-Remus C; Skinner-Taylor C; Goycochea-Robles MV; Bernard-Medina AG; Burgos-Vargas R
    Reumatol Clin; 2012; 8(4):168-73. PubMed ID: 22704914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.
    Rosery H; Bergemann R; Maxion-Bergemann S
    Pharmacoeconomics; 2005; 23(3):243-57. PubMed ID: 15836006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.